Scott Carmer
Keine laufenden Positionen mehr
Profil
Scott Carmer served as President, Chief Executive Officer & Director at NexImmune, Inc. from 2018 to 2022.
Prior to that, he was the Chief Executive Officer at Orgenesis Maryland, Inc. from 2014 to 2016.
He also held positions at Amgen, Inc., Genentech, Inc., MedImmune LLC, and GlaxoSmithKline, Inc. Mr. Carmer received his undergraduate degree from the University of Kentucky.
Ehemalige bekannte Positionen von Scott Carmer
| Unternehmen | Position | Ende |
|---|---|---|
| NEXIMMUNE, INC. | Chief Executive Officer | 12.02.2022 |
Orgenesis Maryland, Inc.
 Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The private company is based in Germantown, MD. | Chief Executive Officer | 18.11.2016 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Ausbildung von Scott Carmer
| University of Kentucky | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NEXIMMUNE, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Orgenesis Maryland, Inc.
Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The private company is based in Germantown, MD. | Health Technology |
